An outbreak of deaths associated with AMB-FUBINACA in Auckland NZ-Reference-Cited by-同舟云学术

An outbreak of deaths associated with AMB-FUBINACA in Auckland NZ

Published:2020-08 Issue: Volume:25 Page:100460
ISSN:2589-5370
Container-title:EClinicalMedicine
language:en
Short-container-title:EClinicalMedicine

Author:

Morrow Paul L^ORCID,Stables Simon,Kesha Kilak,Tse Rexson,Kappatos Diana,Pandey Rishi,Russell Sarah,Linsell Oliver,McCarthy Mary Jane,Spark Amy,Vertes Dianne,Triggs Yvonne,McCarthy Sinead,Cuthers Nanise,Massey Richard

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications;Castaneto;Drug Alcohol Depend,2014

2. World drug report 2019. United nations publication, Sales No. E.19.XI.8.; 2019.

3. “Zombie” Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York;Adams;N Engl J Med,2017

4. Synthetic cannabinoid drug use as a cause or contributory cause of death;Labay;Forensic Sci Int,2016

5. Fatal intoxication with synthetic cannabinoid MDMB-CHMICA;Adamowicz;Forensic Sci Int,2016

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of piperazine and antipsychotic co-exposures and CB1 blockade on the effects elicited by AMB-FUBINACA, a synthetic cannabinoid, in mice;European Journal of Pharmacology;2024-09

2. Potential Implications of Multi-Drug Exposure with Synthetic Cannabinoids: A Scoping Review of Human Case Studies;Psychoactives;2024-08-03

3. CB1 Receptor Negative Allosteric Modulators as a Potential Tool to Reverse Cannabinoid Toxicity;Molecules;2024-04-20

4. Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB1 receptor;Biochemical Pharmacology;2024-04

5. Narrative Review of the Pharmacodynamics, Pharmacokinetics, and Toxicities of Illicit Synthetic Cannabinoid Receptor Agonists;Mini-Reviews in Medicinal Chemistry;2024-01